Free. Unsubscribe any time.
Mineralys Therapeutics, Inc. (MLYS)
Mineralys Therapeutics, Inc. filed 48 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 75 transactions and 990,556 shares. None carries the SEC's AFF10B5ONE flag; all 48 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-25, came 13 days after the one before it (2026-08-12) and reports 3 transactions against 3 in the filing before it.
- The sales it reports total 7,437 shares, 5,267 more than the 2,170 in the filing before it.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 48 filings on file run from 2025-01-15 to 2026-08-25, and state 7 plan adoption dates, from 2023-11-14 to 2026-03-27.
Trades in Mineralys Therapeutics, Inc. 75
- Congleton Jon — 2025-01-13 · S · 18,333 shares
- Levy Adam Scott — 2025-01-13 · S · 10,657 shares
- Levy Adam Scott — 2025-01-13 · S · 100 shares
- Rodman David Malcom — 2025-04-01 · S · 30,574 shares
- Rodman David Malcom — 2025-04-01 · S · 2,791 shares
- Rodman David Malcom — 2025-04-01 · S · 22,406 shares
- Congleton Jon — 2025-04-11 · S · 15,319 shares
- Levy Adam Scott — 2025-04-11 · S · 10,757 shares
- Rodman David Malcom — 2025-04-14 · S · 2,966 shares
- Rodman David Malcom — 2025-04-14 · S · 8,400 shares
- Rodman David Malcom — 2025-05-14 · S · 11,366 shares
- Rodman David Malcom — 2025-06-13 · S · 11,366 shares
Adoption dates in Mineralys Therapeutics, Inc. 7
- 2023-11-14 — stated in 4 filings
- 2024-01-30 — stated in 4 filings
- 2024-10-25 — stated in 9 filings
- 2025-01-28 — stated in 2 filings
- 2025-10-06 — stated in 21 filings
- 2025-12-30 — stated in 5 filings
- 2026-03-27 — stated in 3 filings
Results prints in Mineralys Therapeutics, Inc. 7
- 2025-02-12
- 2025-05-12
- 2025-08-12
- 2025-11-10
- 2026-03-12
- 2026-05-06
- 2026-08-11
Trades before a print in Mineralys Therapeutics, Inc. 3
- 0 days before the 2026-03-12 print — 2026-03-12 · S · Rodman David Malcom · 6,348 shares
- 1 day before the 2026-08-11 print — 2026-08-10 · S · Rodman David Malcom · 2,170 shares
- 3 days before the 2026-03-12 print — 2026-03-09 · S · Rodman David Malcom · 2,171 shares
- 19 days before the 2026-05-06 print — 2026-04-17 · S · Rodman David Malcom · 416 shares
- 21 days before the 2026-05-06 print — 2026-04-15 · S · Rodman David Malcom · 6,348 shares
- 21 days before the 2026-08-11 print — 2026-07-21 · S · Warren Eric · 7,438 shares
- 23 days before the 2026-03-12 print — 2026-02-17 · S · Rodman David Malcom · 417 shares
- 23 days before the 2026-05-06 print — 2026-04-13 · S · Congleton Jon · 15,730 shares
- 23 days before the 2026-05-06 print — 2026-04-13 · S · Rodman David Malcom · 14,058 shares
- 25 days before the 2026-08-11 print — 2026-07-17 · S · Rodman David Malcom · 416 shares
- 26 days before the 2025-11-10 print — 2025-10-15 · S · Rodman David Malcom · 10,369 shares
- 27 days before the 2026-03-12 print — 2026-02-13 · S · Rodman David Malcom · 3,541 shares
Interval to Mineralys Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 3within 5 days
- 3within 10 days
- 0shortest, days
- 1no later print
- Rodman David Malcom 2026-03-09 · S · 3 days before the 2026-03-12 print · Chief Medical Officer
- Rodman David Malcom 2026-03-12 · S · 0 days before the 2026-03-12 print · Chief Medical Officer
- Rodman David Malcom 2026-08-10 · S · 1 day before the 2026-08-11 print · Chief Medical Officer
Adoption dates Mineralys Therapeutics, Inc. states
- 2023-11-14 in 4 filings
- 2024-01-30 in 4 filings
- 2024-10-25 in 9 filings
- 2025-01-28 in 2 filings
- 2025-10-06 in 21 filings
- 2025-12-30 in 5 filings
- 2026-03-27 in 3 filings
Filing text: “10b5-1 trading plan adopted on January 28, 2025”
Reported results dates on file
- 2025-02-12
- 2025-05-12
- 2025-08-12
- 2025-11-10
- 2026-03-12
- 2026-05-06
- 2026-08-11
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.